PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 189 results · Cardiovascular  · Clear
🔒 Subscribers only
AUTH/3666/6/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo breached ABPI Code over HSJ sponsored article transparency (AUTH/3666/6/22)
An anonymous health professional complained about an online article in the Health Service Journal (HSJ) published on World Stroke Day (29 October 2019) titled “Addressing variations in the diagno…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3637/4/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
An anonymous complainant challenged Daiichi Sankyo’s myldltreatment patient website for people prescribed Nilemdo (bempedoic acid) or Nustendi (bempedoic acid/ezetimibe).The complainant alleged t…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3635/4/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis Entresto podcast
An anonymous cardiac specialist health professional complained about Episode 2 of Novartis’ ‘Heart to Heart’ podcast series promoting Entresto (sacubitril/valsartan).The podcast was developed…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3654/5/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis
A health professional complained about a Novartis promotional symposium video for Entresto (sacubitril/valsartan) hosted on a learned society’s website after a September 2021 conference (video ML…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3649/5/22
Off-label Promotion Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo breached Code over SMC summary card
An anonymous health professional complained about a 4-page electronic SMC guidelines summary card for Nilemdo (bempedoic acid) and Nustendi (bempedoic acid/ezetimibe) (Job code BEM/21/0732, prepare…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3648/5/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis
An anonymous complainant challenged a December 2020 “Heart Failure Primary Care Leaders Network” virtual meeting and a 5-page meeting write-up hosted on a healthcare organisation’s website. T…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3655/6/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis breached Code over Mayzent web page implying initiation was suitable for patients with rece
An anonymous health professional complained about the ‘Dosing and administration’ page for Mayzent (siponimod) on www.health.novartis.co.uk (UK | January 2021 | 104535).The page’s ‘Addition…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3670/6/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis
A health professional complained about a Novartis webinar registration webpage for Leqvio (inclisiran) titled: “Introducing an innovative approach to lipid management with inclisiran (Leqvio)”.…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3665/6/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis breached Clause 6.1 and 5.1 over ‘1st line’ Entresto guideline claim lacking HFrEF definiti
An anonymous, contactable health professional complained about promotional claims for Entresto (sacubitril/valsartan) on Novartis’ health.novartis.co.uk website (UK | October 2021 materials). T…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3679/8/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
CSL Vifor
An anonymous complainant challenged claims in a Ferinject (ferric carboxymaltose) promotional supplement published on the British Journal of Cardiology website (article: “Intravenous iron therapi…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3689/8/22
Social Media & Digital Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
CSL Vifor
CSL Vifor made a voluntary admission about promotional activities linked to the European Society of Cardiology – Heart Failure Association (ESC-HFA) conference (May 2022).A third party ran a sequ…
Clauses: 9.1,26.1
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3673/7/22
Off-label Promotion Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo press release on Nilemdo/Nustendi
An anonymous, contactable complainant challenged a Daiichi Sankyo UK press release about Nilemdo (bempedoic acid) and Nustendi (bempedoic acid/ezetimibe). The press release (issued to UK journalist…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3467/2/21
Off-label Promotion Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Anonymous GP v Pfizer
An anonymous, non-contactable complainant describing themself as a GP complained about a named Pfizer representative’s promotion of Eliquis (apixaban), an anticoagulant.The GP alleged the represe…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3462/1/21
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Boehringer Ingelheim
An independent member of the Code of Practice Appeal Board (acting as a health professional) complained about the Pradaxa (dabigatran) HCP website (pradaxa.co.uk) regarding NVAF stroke prevention d…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3498/3/21
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
LEO Pharma
An anonymous, contactable ex-employee complained about LEO Pharma UK/IE’s public disclosures of support to patient organisations (company website list and Disclosure UK).The complaint focused on …
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3499/4/21
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi-Sankyo website page promoted Efient and Lixiana to the public and breached a prior undertaki
An anonymous complainant alleged Daiichi-Sankyo promoted prescription-only medicines (Efient/prasugrel and Lixiana/edoxaban) to the public via a corporate website page.The page included brand and g…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3506/4/21
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi-Sankyo
A complainant (later non-contactable) challenged a two-page hard-copy journal advertisement for Lixiana (edoxaban) in Guidelines in Practice (March 2021, Vol 24, Issue 3).The ad (job code EDX/20/11…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3504/4/21
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi-Sankyo
A complainant raised concerns about multiple webpages on Daiichi-Sankyo UK’s HCP website promoting Nilemdo (bempedoic acid) and Nustendi (bempedoic acid/ezetimibe) (Job Code BEM/20/0242; prepared…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3507/5/21
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi-Sankyo
An anonymous complainant raised two related complaints about promotion of Lixiana (edoxaban) linked to a sponsored symposium: “Anticoagulation in stroke prevention: Optimising clinical and medici…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3497/3/21
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
An anonymous complainant challenged content on two Daiichi Sankyo websites relating to Lixiana (edoxaban): an HCP site (lixiana-hcp.co.uk) and a patient-directed site (myanticoagulant.co.uk).Multip…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3542/7/21
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi-Sankyo
An anonymous (initially contactable) health professional complained about Daiichi-Sankyo UK promotional materials in Guidelines in practice (hard copy and digital).The hard copy journal ad for Nile…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3563/9/21
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Bristol-Myers Squibb & Pfizer
A health professional complainant accessed the Eliquis.co.uk health professional (HCP) section via the ‘I am a HCP’ tab.They objected to the repeated banner headline “Choose Eliquis”, alleg…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3594/12/21
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
A health professional complained about Daiichi-Sankyo UK Ltd’s relationship with a named patient organisation running a public disease awareness programme, “Get clued-up on cholesterol”.The p…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3393/10/20
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Boehringer Ingelheim
An anonymous, non-contactable complainant (self-described health professional) complained about Boehringer Ingelheim social media activity (tweets and Facebook posts) advertising a webinar: “How …
Clauses: NONE
2020 🔒 Subscribe
← Prev 1 2 3 4 5 Next → Page 2 of 8 — 189 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews